CRISPR Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China – GlobeNewswire (press release)
|
CRISPR Therapeutics Announces Patent for CRISPR/Cas Genome Editing in China
GlobeNewswire (press release) BASEL, Switzerland, June 19, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics (NASDAQ:CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, announced that China's State Intellectual … |
